Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1704629 | 0.85 | SOAT1 (0.64) | SOAT1RAB9A | |
| Hydrochloric Acid SCHEMBL1704598 | 0.84 | SOAT1 (0.64) | SOAT1RAB9A | |
| SCHEMBL4525437 | 0.83 | SOAT1 (0.68) | SOAT1RAB9A | |
| SCHEMBL6102306 | 0.82 | SOAT1 (0.78) | SOAT1RAB9A | |
| SCHEMBL4984903 | 0.81 | SOAT1 (1.00) | SOAT1 | |
| SCHEMBL6279654 | 0.81 | SOAT1 (0.87) | SOAT1 | |
| SCHEMBL6100261 | 0.81 | SOAT1 (1.00) | SOAT1 | |
| SCHEMBL960484 | 0.80 | SOAT1 (1.00) | SOAT1RAB9A | |
| SCHEMBL29845569 | 0.80 | SOAT1 (1.00) | SOAT1RAB9A | |
| Hydrochloric Acid SCHEMBL1704627 | 0.80 | SOAT1 (1.00) | SOAT1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7560547-B2 | Hydroxyalkyl cyclic diamine compounds | KOWA CO., LTD. (JP) | 2009-07-14 | — | — | US | disclosed |
| US-20070088159-A1 | HYDROXYALKYL CYCLIC DIAMINE COMPOUNDS | KOWA CO., LTD. (JP) | 2007-04-19 | — | — | US | disclosed |
| US-7176306-B2 | Hydroxyalkyl cyclic diamine compound | KOWA CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| EP-1571144-A1 | HYDROXYALKYLATED CYCLIC DIAMINE COMPOUND | Kowa Co., Ltd. (JP) | 2005-09-07 | — | — | EP | disclosed |
| US-20040176593-A1 | Hydroxyalkyl cyclic diamine compound | KOWA CO., LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176593-A1 | Hydroxyalkyl cyclic diamine compound | DDC, AOC1, ODC1 | SOAT1 1314/4885RAB9A 2895/4885 |
| US-20070088159-A1 | HYDROXYALKYL CYCLIC DIAMINE COMPOUNDS | HDHD5, DDC, DDT | SOAT1 1023/4885RAB9A 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.